Shrink Nanotechnologies Signs Exclusive Worldwide Licensing Agreement with Corning for Modular Microfluidic System
08 Outubro 2010 - 5:00PM
Business Wire
Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an
innovative nanotechnology company developing products and licensing
opportunities in the solar energy production, medical diagnostics
and sensors, and biotechnology research and development tools
businesses, announced today that it has entered into a licensing
agreement with Corning Incorporated (NYSE: GLW).
In exchange for a commercial royalty, Shrink retains an
exclusive right to use and sublicense Corning’s patent-pending
modular microfluidic system for at least eight years.
The patent-pending Corning modular microfluidic system has been
widely published and has generated significant interest from
commercial and academic interests since it was first published in
2008 in Lab on a Chip, a high impact academic journal. This system
is the world’s first fully functional plug and play modular
microfluidics system that truly allows for integrated high PSI
connectors, electronics and pumps. This system is capable of being
used in numerous commercial research applications where ultra-fast
microfluidic design prototyping is desired, in biochemical,
biomedical and cell-based drug discovery applications to name a
few. Shrink intends to develop this system as a premium
microfluidic product offering throughout North America, Europe and
Asia.
Click here for more information about this new system:
http://www.shrinknano.com/corning-relationship
“One of Shrink’s missions within its ShrinkChips Subsidiary is
to make low cost, high quality, integrated and flexible
microfluidic systems for a growing microfluidics market. In order
to compliment our lower cost NanoShrink brand offerings, which will
launch this year, we are pleased to be able to also design, build
and offer for sale, a platform based on Corning’s patent-pending
modular system, which we believe is truly unique and gives
researchers unparalleled flexibility to, ‘on the fly,’ conduct
important biotechnology experiments,” said Mark L. Baum, CEO of
Shrink Nanotechnologies, Inc. Baum continued, “Corning’s Corporate
Research Lab is an extremely impressive organization with
tremendous resources that we believe we will be able to leverage
over the coming year as we develop this unique technology. We look
forward to working with Corning’s team to make this agreement a
success and to get this important technology to market.”
About Shrink Nanotechnologies, Inc.
Shrink Nanotechnologies, Inc. (www.shrinknano.com) is a
one-of-a-kind FIGA™ organization, which focuses on leveraging
contributions from experts in Finance, Industry, Government and
Academia. Operating as a high-technology development-stage company,
Shrink owns and develops proprietary and patent-pending nano-sized
technologies, components and product systems. The Company's unique
NanoShrink™ material is a pre-stressed polymer which is used in a
patent pending manufacturing platform with numerous applications in
the solar energy, human and animal diagnostics, and biotechnology
research and development tools industries.
Statements contained herein that are not historical facts may be
forward-looking statements within the meaning of the Securities Act
of 1933, as amended. Forward-looking statements include statements
regarding the intent, belief or current expectations of Shrink
Nanotechnologies and Corning Incorporated and their respective
management teams. Such statements are estimates only. Actual
results may differ materially from those anticipated in this press
release. Such statements reflect management’s current views, are
based on certain assumptions and involve risks and uncertainties.
Actual results, events, or performance may differ materially from
the above forward-looking statements due to a number of important
factors, and will be dependent upon a variety of factors,
including, but not limited to Shrink’s ability to obtain additional
financing and to build and develop markets for Shrink’s
biotechnology technologies and products, including those discussed
in this press release. These factors should be strongly considered
when making a decision to acquire or maintain a financial interest
in Shrink, including consulting with a FINRA registered
representative prior to making such decision. Shrink undertakes no
obligation to publicly update these forward-looking statements to
reflect events or circumstances that occur after the date hereof or
to reflect any change in Shrink’s expectations with regard to these
forward-looking statements or the occurrence of unanticipated
events. Factors that may impact Shrink’s success are more fully
disclosed in Shrink’s most recent public filings with the U.S.
Securities and Exchange Commission.
Corning (NYSE:GLW)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Corning (NYSE:GLW)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024